Outlook Therapeutics, Inc. - Common Stock —— 季度资产负债表 (NASDAQ:OTLK) | MetaTrader

展开完整图表

新闻

Outlook Therapeutics: Potential Catalysts Offering An Arbitrage Opportunity (NASDAQ:OTLK)

Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates

Outlook Therapeutics Files FDA Resolution Request After Rejection For Vision Loss Drug - Outlook Therapeu

Outlook Therapeutics获得1840万美元票据融资并延长债务到期日

Outlook Therapeutics secures $18.4M note, extends debt maturity

Outlook Therapeutics就贝伐珠单抗药物与FDA会议进行讨论

Outlook Therapeutics discusses FDA meeting on bevacizumab drug

Oncobiologics, Inc. (OTLK) Reports Q1 Loss, Misses Revenue Estimates

OTLK Stock Crashes 67% in a Week: Here's What You Need to Know

Outlook Therapeutics任命Laura Cantrell为企业战略副总裁

H.C. Wainwright将Outlook Therapeutics目标股价下调至0.50美元

Outlook Therapeutics stock price target lowered to $0.50 at H.C. Wainwright